Greenhouse Funds LLLP Purchases 157,106 Shares of HealthEquity, Inc. $HQY

Greenhouse Funds LLLP boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 17.2% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,068,921 shares of the company’s stock after buying an additional 157,106 shares during the quarter. HealthEquity accounts for 3.7% of Greenhouse Funds LLLP’s investment portfolio, making the stock its 8th biggest holding. Greenhouse Funds LLLP’s holdings in HealthEquity were worth $101,302,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in HQY. True Wealth Design LLC grew its position in shares of HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after acquiring an additional 317 shares during the period. Farther Finance Advisors LLC raised its holdings in shares of HealthEquity by 59.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after purchasing an additional 146 shares during the period. AlphaQuest LLC raised its holdings in shares of HealthEquity by 52.2% in the 3rd quarter. AlphaQuest LLC now owns 624 shares of the company’s stock valued at $59,000 after purchasing an additional 214 shares during the period. Allworth Financial LP lifted its stake in HealthEquity by 283.1% in the 2nd quarter. Allworth Financial LP now owns 747 shares of the company’s stock valued at $78,000 after purchasing an additional 552 shares during the last quarter. Finally, SBI Securities Co. Ltd. lifted its stake in HealthEquity by 25,100.0% in the 2nd quarter. SBI Securities Co. Ltd. now owns 756 shares of the company’s stock valued at $79,000 after purchasing an additional 753 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Buying and Selling

In other news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.50% of the company’s stock.

HealthEquity Stock Up 0.1%

HealthEquity stock opened at $78.57 on Thursday. The stock has a market cap of $6.71 billion, a P/E ratio of 36.04, a P/E/G ratio of 0.98 and a beta of 0.26. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $116.65. The company’s 50-day moving average price is $82.48 and its two-hundred day moving average price is $90.55.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of recent analyst reports. Barclays lowered their price target on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. Raymond James Financial set a $100.00 target price on HealthEquity in a research note on Tuesday, February 17th. JPMorgan Chase & Co. boosted their target price on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a report on Thursday, December 4th. Finally, BTIG Research cut their price target on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $112.00.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.